Bioorganic and Medicinal Chemistry Letters p. 295 - 300 (1999)
Update date:2022-08-02
Topics:
Nelson, Frances C.
Stachel, Shawn J.
Eng
Sehgal, Suren N.
A novel series of rapamycin derivatives with modifications in the C(22)- C(27) region has been prepared. These compounds are evaluated for their ability to prevent ring fragmentation while still retaining immunosuppressive capabilities.
View MoreShenyang Xingzhenghe Chemical Co., Ltd.
Contact:024-23509232
Address:No. 33, Naner Road, Heping Dist.
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Xi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Contact:021-50278900
Address:No.6,Room 201 ,Lane 299,bisheng road ,shanghai ,china
Doi:10.1016/0008-6215(94)90022-1
(1994)Doi:10.1134/S107036321801005X
()Doi:10.1021/bc5000115
(2014)Doi:10.1016/S0020-1693(99)00523-X
(2000)Doi:10.1039/c5cc03038b
(2015)Doi:10.3987/COM-93-6556
(1994)
